Hydralazine Administration Guidelines

Assessment of Blood Pressure Reading

The American College of Cardiology guidelines indicate that a blood pressure reading of 139/57 mmHg does not meet criteria for hypertension, as it is below the threshold of 140/90 mmHg 1
The diastolic reading of 57 mmHg is actually low and indicates potential risk for hypotension if blood pressure is further reduced, according to Circulation guidelines 2

Hydralazine is a direct vasodilator that can cause significant blood pressure reduction, with effects beginning within 10-30 minutes and lasting 2-4 hours, as stated by the American College of Cardiology and Circulation guidelines 1, 2
Hydralazine has unpredictable response and prolonged duration of action, making it unsuitable for use in non-urgent situations, especially with borderline or normal blood pressure, according to the American College of Cardiology and Circulation guidelines 1, 3

The American College of Cardiology recommends hydralazine for hypertensive emergencies when administered intravenously, and as a step 5 agent in resistant hypertension management 1, 2
The European Heart Journal and European Journal of Heart Failure suggest hydralazine in combination with isosorbide dinitrate for heart failure with reduced ejection fraction 4, 5
Hydralazine is not recommended as a first-line agent for acute treatment in most patients due to unpredictability of response and prolonged duration of action, as stated by the American College of Cardiology and Circulation guidelines 1, 3

For a blood pressure of 139/57 mmHg, the American College of Cardiology and Circulation guidelines recommend withholding scheduled hydralazine and monitoring blood pressure for trends rather than treating a single reading 1, 2
If the patient is on scheduled hydralazine for another indication, such as heart failure, the European Heart Journal and European Journal of Heart Failure suggest consulting with the prescribing physician about temporarily holding the dose 4, 5
The American College of Cardiology and Circulation guidelines recommend considering evaluation for causes of low diastolic pressure if this is a persistent finding 2, 3
For patients with true hypertension requiring treatment, the Hypertension guidelines recommend following a stepwise approach to hypertension management and reserving hydralazine for specific indications such as resistant hypertension or hypertensive emergencies 6, 7

The European Society of Cardiology guidelines note that symptomatic hypotension from hydralazine-isosorbide dinitrate therapy should prompt dose reduction, and asymptomatic hypotension does not require intervention—but a diastolic of 45 mmHg warrants clinical concern regardless 8
Heart failure with reduced ejection fraction in combination with isosorbide dinitrate, particularly in African American patients, is an appropriate clinical scenario for hydralazine use, according to the European Society of Cardiology 8